These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 25916722

  • 1. Efficacy of B-Type Natriuretic Peptide Is Coupled to Phosphodiesterase 2A in Cardiac Sympathetic Neurons.
    Li D, Lu CJ, Hao G, Wright H, Woodward L, Liu K, Vergari E, Surdo NC, Herring N, Zaccolo M, Paterson DJ.
    Hypertension; 2015 Jul; 66(1):190-8. PubMed ID: 25916722
    [Abstract] [Full Text] [Related]

  • 2. Phosphodiesterase 2A as a therapeutic target to restore cardiac neurotransmission during sympathetic hyperactivity.
    Liu K, Li D, Hao G, McCaffary D, Neely O, Woodward L, Ioannides D, Lu CJ, Brescia M, Zaccolo M, Tandri H, Ajijola OA, Ardell JL, Shivkumar K, Paterson DJ.
    JCI Insight; 2018 May 03; 3(9):. PubMed ID: 29720569
    [Abstract] [Full Text] [Related]

  • 3. Modulation by brain natriuretic peptide of GABA receptors on rat retinal ON-type bipolar cells.
    Yu YC, Cao LH, Yang XL.
    J Neurosci; 2006 Jan 11; 26(2):696-707. PubMed ID: 16407567
    [Abstract] [Full Text] [Related]

  • 4. Natriuretic peptide-induced catecholamine release from cardiac sympathetic neurons: inhibition by histamine H3 and H4 receptor activation.
    Chan NY, Robador PA, Levi R.
    J Pharmacol Exp Ther; 2012 Dec 11; 343(3):568-77. PubMed ID: 22923736
    [Abstract] [Full Text] [Related]

  • 5. Emerging Role of Phosphodiesterase 2A in Hypertension.
    Seifert R.
    Hypertension; 2015 Jul 11; 66(1):13-4. PubMed ID: 25916726
    [No Abstract] [Full Text] [Related]

  • 6. C-type natriuretic peptide and natriuretic peptide receptor B signalling inhibits cardiac sympathetic neurotransmission and autonomic function.
    Buttgereit J, Shanks J, Li D, Hao G, Athwal A, Langenickel TH, Wright H, da Costa Goncalves AC, Monti J, Plehm R, Popova E, Qadri F, Lapidus I, Ryan B, Özcelik C, Paterson DJ, Bader M, Herring N.
    Cardiovasc Res; 2016 Dec 11; 112(3):637-644. PubMed ID: 27496871
    [Abstract] [Full Text] [Related]

  • 7. Relevance of brain natriuretic peptide in preload-dependent regulation of cardiac sarcoplasmic reticulum Ca2+ ATPase expression.
    Kögler H, Schott P, Toischer K, Milting H, Van PN, Kohlhaas M, Grebe C, Kassner A, Domeier E, Teucher N, Seidler T, Knöll R, Maier LS, El-Banayosy A, Körfer R, Hasenfuss G.
    Circulation; 2006 Jun 13; 113(23):2724-32. PubMed ID: 16754798
    [Abstract] [Full Text] [Related]

  • 8. Inhibitory effects of natriuretic peptides on vasopressin neurons mediated through cGMP and cGMP-dependent protein kinase in vitro.
    Akamatsu N, Inenaga K, Yamashita H.
    J Neuroendocrinol; 1993 Oct 13; 5(5):517-22. PubMed ID: 8680419
    [Abstract] [Full Text] [Related]

  • 9. An unsuspected property of natriuretic peptides: promotion of calcium-dependent catecholamine release via protein kinase G-mediated phosphodiesterase type 3 inhibition.
    Chan NY, Seyedi N, Takano K, Levi R.
    Circulation; 2012 Jan 17; 125(2):298-307. PubMed ID: 22158783
    [Abstract] [Full Text] [Related]

  • 10. Dysregulation of Neuronal Ca2+ Channel Linked to Heightened Sympathetic Phenotype in Prohypertensive States.
    Larsen HE, Bardsley EN, Lefkimmiatis K, Paterson DJ.
    J Neurosci; 2016 Aug 17; 36(33):8562-73. PubMed ID: 27535905
    [Abstract] [Full Text] [Related]

  • 11. Natriuretic peptides like NO facilitate cardiac vagal neurotransmission and bradycardia via a cGMP pathway.
    Herring N, Zaman JA, Paterson DJ.
    Am J Physiol Heart Circ Physiol; 2001 Dec 17; 281(6):H2318-27. PubMed ID: 11709398
    [Abstract] [Full Text] [Related]

  • 12. Phosphodiesterase-2 is up-regulated in human failing hearts and blunts β-adrenergic responses in cardiomyocytes.
    Mehel H, Emons J, Vettel C, Wittköpper K, Seppelt D, Dewenter M, Lutz S, Sossalla S, Maier LS, Lechêne P, Leroy J, Lefebvre F, Varin A, Eschenhagen T, Nattel S, Dobrev D, Zimmermann WH, Nikolaev VO, Vandecasteele G, Fischmeister R, El-Armouche A.
    J Am Coll Cardiol; 2013 Oct 22; 62(17):1596-606. PubMed ID: 23810893
    [Abstract] [Full Text] [Related]

  • 13. Different compartmentation of responses to brain natriuretic peptide and C-type natriuretic peptide in failing rat ventricle.
    Moltzau LR, Aronsen JM, Meier S, Skogestad J, Ørstavik Ø, Lothe GB, Sjaastad I, Skomedal T, Osnes JB, Levy FO, Qvigstad E.
    J Pharmacol Exp Ther; 2014 Sep 22; 350(3):681-90. PubMed ID: 25022512
    [Abstract] [Full Text] [Related]

  • 14. Neuronal nitric oxide synthase gene transfer decreases [Ca2+]i in cardiac sympathetic neurons.
    Wang L, Henrich M, Buckler KJ, McMenamin M, Mee CJ, Sattelle DB, Paterson DJ.
    J Mol Cell Cardiol; 2007 Dec 22; 43(6):717-25. PubMed ID: 17961591
    [Abstract] [Full Text] [Related]

  • 15. Acute phosphodiesterase 5 inhibition mimics hemodynamic effects of B-type natriuretic peptide and potentiates B-type natriuretic peptide effects in failing but not normal canine heart.
    Forfia PR, Lee M, Tunin RS, Mahmud M, Champion HC, Kass DA.
    J Am Coll Cardiol; 2007 Mar 13; 49(10):1079-88. PubMed ID: 17349888
    [Abstract] [Full Text] [Related]

  • 16. Maximizing the renal cyclic 3'-5'-guanosine monophosphate system with type V phosphodiesterase inhibition and exogenous natriuretic peptide: a novel strategy to improve renal function in experimental overt heart failure.
    Chen HH, Huntley BK, Schirger JA, Cataliotti A, Burnett JC.
    J Am Soc Nephrol; 2006 Oct 13; 17(10):2742-7. PubMed ID: 16928803
    [Abstract] [Full Text] [Related]

  • 17. B-Type Natriuretic Peptide Modulates Pulmonary Vein Arrhythmogenesis: A Novel Potential Contributor to the Genesis of Atrial Tachyarrhythmia in Heart Failure.
    Lin YK, Chen YC, Chen YA, Yeh YH, Chen SA, Chen YJ.
    J Cardiovasc Electrophysiol; 2016 Dec 13; 27(12):1462-1471. PubMed ID: 27571932
    [Abstract] [Full Text] [Related]

  • 18. PDE2-mediated cAMP hydrolysis accelerates cardiac fibroblast to myofibroblast conversion and is antagonized by exogenous activation of cGMP signaling pathways.
    Vettel C, Lämmle S, Ewens S, Cervirgen C, Emons J, Ongherth A, Dewenter M, Lindner D, Westermann D, Nikolaev VO, Lutz S, Zimmermann WH, El-Armouche A.
    Am J Physiol Heart Circ Physiol; 2014 Apr 15; 306(8):H1246-52. PubMed ID: 24531807
    [Abstract] [Full Text] [Related]

  • 19. Brain natriuretic peptide enhances the endothelium-independent cAMP and vasorelaxant responses of calcitonin gene-related peptide in rat aorta.
    Fiscus RR, Lu L, Tu AW, Hao H, Yang L, Wang X.
    Neuropeptides; 1998 Dec 15; 32(6):499-509. PubMed ID: 9920447
    [Abstract] [Full Text] [Related]

  • 20. Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5.
    Takimoto E, Belardi D, Tocchetti CG, Vahebi S, Cormaci G, Ketner EA, Moens AL, Champion HC, Kass DA.
    Circulation; 2007 Apr 24; 115(16):2159-67. PubMed ID: 17420342
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.